Bharat Biotech
-
Covaxin booster dose trial shows 'long-term safety', claims Bharat Biotech
India | Jan 08, 2022, 10:41 PM ISTThe Covaxin booster dose trial was performed on subjects 6 months after they received the second dose of the vaccine.
-
Bharat Biotech says paracetamol, painkillers not required for teens after getting Covaxin jab
India | Jan 05, 2022, 10:08 PM ISTBharat Biotech in a Twitter post said that no paracetamol or painkillers are recommended after being vaccinated with Covaxin.
-
Bharat Biotech's nasal Covid booster dose gets DCGI approval for Phase III trial
India | Jan 05, 2022, 12:46 PM ISTBharat Biotech aims to conduct clinical trials on 5,000 subjects (50 per cent vaccinated with Covishield and 50 per cent vaccinated with Covaxin).
-
Bharat Biotech's nasal vaccine for booster dose? Key meeting today
India | Jan 04, 2022, 03:00 PM ISTAccording to reports, Bharat Biotech has proposed that its nasal vaccine can be used as booster dose for those who have already been inoculated with Covaxin or Covishield vaccines against coronavirus.
-
Bharat Biotech to commence exports of Covaxin to additional countries from December
India | Nov 29, 2021, 04:04 PM ISTEarlier last week, vaccine major Serum Institute of India had said that it has resumed exports of its vaccine Covishield to the international vaccine sharing program COVAX.
-
Lancet Infectious Diseases study compare well with phase 3 COVAXIN clinical trials: Bharat Biotech
India | Nov 25, 2021, 12:33 PM IST2 doses of COVID vaccine Covaxin (BBV152) are 50 pc effective against symptomatic COVID disease, according to 1st real-world assessment of COVID vaccine published in the Lancet Infectious Diseases journal.
-
UK includes India's Covaxin on list of approved vaccines for international travellers
India | Nov 22, 2021, 09:43 PM ISTThe step will benefit more fully vaccinated Indians planning travel to the UK without the need for a pre-departure PCR test or self-isolation at the address declared on their compulsory Passenger Locator Forms.
-
Developing 'Covaxin' was an enormous challenge: Bharat Biotech
India | Nov 19, 2021, 08:30 AM ISTBharat Biotech was successful in releasing Covaxin in a record time and helped to save lives of crores of fellow Indians, says Director V Krishna Mohan.
-
COVID: Bahrain approves Bharat Biotech's Covaxin
World | Nov 12, 2021, 02:50 PM ISTThe approval comes days after Covaxin received the emergency use listing from WHO.
-
Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy against COVID, says Lancet
India | Nov 12, 2021, 09:12 AM ISTRecently, WHO granted emergency use listing to Covaxin enabling countries to expedite their regulatory approval to import and administer doses.
-
Looking at nasal vaccine as booster dose, says Covaxin maker Bharat Biotech
India | Nov 10, 2021, 03:33 PM ISTBharat Biotech Chairman and MD Krishna Ella said that the company is looking at nasal vaccine as a booster dose as its scaling up capacity is very easy when compared with Covaxin.
-
Covaxin approved by Hong Kong for international travellers
India | Nov 10, 2021, 02:18 PM ISTOn November 3, the World Health Organisation (WHO) had granted emergency use approval for Covaxin.
-
Bharat Biotech's partner seeks Covaxin approval in US for children
India | Nov 06, 2021, 10:59 AM ISTBharat Biotech's Covaxin and AstraZeneca and Serum Institute's Covishield are the two widely used vaccines in India.
-
Covaxin gets shelf life extension up to 12 months: Bharat Biotech
India | Nov 03, 2021, 04:34 PM ISTIn a tweet, Bharat Biotech said, "The CDSCO has approved the extension of shelf life of Covaxin up to 12 months, from the date of manufacture. This approval of shelf life extension is based on the availability of additional stability data, which was submitted to CDSCO."
-
Bharat Biotech's Covaxin added to approved list of COVID vaccines for travel to Australia
India | Nov 01, 2021, 01:01 PM ISTMeanwhile, Covaxin is yet to receive approval from the World Health Organisation, which last week said it expects to receive clarifications from Bharat Biotech.
-
Despite quick submission of data, WHO denies approval to Bharat Biotech's Covaxin
India | Oct 29, 2021, 01:33 PM ISTHyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI to WHO on April 19 for the vaccine's Emergency Use Listing.
-
Recommendation of Covaxin in less than 24 hours: WHO Official
India | Oct 26, 2021, 05:22 PM ISTEarlier this week, the global health organisation had said in a tweet that it is expecting one additional piece of information from Bharat Biotech regarding COVAXIN.
-
PM Modi meets Indian COVID-19 vaccine manufacturers after Billion doses feat
India | Oct 23, 2021, 08:17 PM ISTRepresentatives from seven vaccine makers -- Serum Institute of India, Bharat Biotech, Dr Reddy's Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech -- participated in the meeting.
-
Covid: Expert panel recommends emergency use Covaxin for 2-18 age group
News | Oct 12, 2021, 04:27 PM ISTAn expert panel of the Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain conditions. With this, Covaxin becomes the first COVID-19 vaccine that can be administered to children in India.
-
Final decision on emergency use of Covaxin by next week: WHO
India | Oct 05, 2021, 09:06 PM ISTThe World Health Organisation (WHO) on Tuesday informed that the decision on Emergency Use Listing (EUL) authorisation of Bharat Biotech’s Covid-19 vaccine 'Covaxin' will be finalised next week.